Drugs that contain Milnacipran Hydrochloride
1. Savella patents expiration
Can you believe SAVELLA received compensation for the extended wait time during the regulatory approval process?
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6992110 | ABBVIE | Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain |
Nov, 2021
(2 years ago) | |
| US7888342 | ABBVIE | Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain |
Nov, 2021
(2 years ago) | |
| US6602911 | ABBVIE | Methods of treating fibromyalgia |
Jan, 2023
(1 year, 3 months ago) | |
| US7994220 | ABBVIE | Milnacipran for the long-term treatment of fibromyalgia syndrome |
Sep, 2029
(5 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Jan 14, 2014 |
NCE-1 date: 14 January, 2013
Market Authorisation Date: 14 January, 2009
Treatment: Management of fibromyalgia (fm); Management of fibromyalgia
Dosage: TABLET;ORAL
How can I launch a generic of SAVELLA before it's drug patent expiration?
More Information on Dosage
SAVELLA family patents
